Literature DB >> 21206859

Is oestrogen a 'biological neuroleptic'?

Subhagata Chattopadyay1.   

Abstract

OBJECTIVE: Oestrogen-hypothesis in schizophrenia is a largely debated issue. Being a multifactor disorder, schizophrenia has gained importance in the field of psychiatric research, especially to dig out the tentative aetiologies (genetic, biological, environmental etc.), still under tested or not tested. The present article is an attempt only to understand the possible role of oestrogen as a 'core' biological factor at the backdrop of male-female differences (in the onset, course, treatment response, prognosis) in schizophrenia barring other factors. This is to reduce the level of 'conflict' and 'confusion' in the article.
METHOD: Electronic data search is the mainstay of the literature bank, included in the article and only 'supportive' evidences (direct and indirect) are incorporated to understand the role of oestrogen in the brain at the backdrop of schizophrenia. RESULT: The study comes out with a postulation that oestrogen has got a potential effect in moderating the process of schizophrenia in the females.
CONCLUSION: Oestrogen could be tested as the 'novel' therapeutic agent in the female schizophrenics with the necessary support from the modern Nuclear Imaging Techniques to get maximum therapeutic benefit in schizophrenia.

Entities:  

Keywords:  dopamine; oestrogen; schizophrenia; serotonin

Year:  2003        PMID: 21206859      PMCID: PMC2952365     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  20 in total

Review 1.  Neuroprotection by estradiol.

Authors:  L M Garcia-Segura; I Azcoitia; L L DonCarlos
Journal:  Prog Neurobiol       Date:  2001-01       Impact factor: 11.685

2.  Estrogen - a potential treatment for schizophrenia.

Authors:  J Kulkarni; A Riedel; A R de Castella; P B Fitzgerald; T J Rolfe; J Taffe; H Burger
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

3.  Association of estrogen levels with neuropsychological performance in women with schizophrenia.

Authors:  A L Hoff; W S Kremen; M H Wieneke; J Lauriello; H M Blankfeld; W O Faustman; J G Csernansky; T E Nordahl
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

4.  Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain.

Authors:  M K Osterlund; C Halldin; Y L Hurd
Journal:  Synapse       Date:  2000-01       Impact factor: 2.562

Review 5.  Gender, estrogen, and schizophrenia.

Authors:  L A Lindamer; J B Lohr; M J Harris; D V Jeste
Journal:  Psychopharmacol Bull       Date:  1997

Review 6.  Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory.

Authors:  G Fink; B Sumner; R Rosie; H Wilson; J McQueen
Journal:  Behav Brain Res       Date:  1999-11-01       Impact factor: 3.332

Review 7.  Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders.

Authors:  J C Huber; C Schneeberger; C B Tempfer
Journal:  Maturitas       Date:  2002-05-20       Impact factor: 4.342

8.  Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain.

Authors:  B E Sumner; G Fink
Journal:  Brain Res Mol Brain Res       Date:  1998-08-31

9.  Impact of childbirth on a series of schizophrenic mothers: a comment on the possible influence of oestrogen on schizophrenia.

Authors:  A Davies; R J McIvor; R C Kumar
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

Review 10.  The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women.

Authors:  Sophie Grigoriadis; Mary V Seeman
Journal:  Can J Psychiatry       Date:  2002-06       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.